Statistics

Total Visits

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study16

File Visits

Downloads
41131-1808.pdf7

Select a period of time:

Number of views in the range

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study13

Number of downloads in the range

Downloads
41131-1808.pdf4

Views

Views
January 20246
February 20240
March 20241
April 20241
May 20243
June 20242
July 20240
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • January 2024
    1
  • February 2024
    0
  • March 2024
    1
  • April 2024
    0
  • May 2024
    0
  • June 2024
    2
  • July 2024
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
 

Top countries by downloads

Downloads
United States4
 

Top cities views

Views
Boardman6
Chicago2
Fort Worth1
 

Top cities by downloads

Downloads
Chicago1